Published in Gene Therapy Weekly, March 17th, 1997
RSV is the principle cause of lower respiratory infections such as pneumonia and brochiolitis in infants and children, and is responsible for at least 90,000 hospitalizations and 4,500 deaths in the United States each year.
The Cleveland Clinic, Ohio, conducted the study in collaboration with the U.S. National Institutes of Health (NIH). Gemini Technologies, Inc. is the exclusive licensee of the 2-5A antisense technology. Results of the study...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.